Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in children and adolescents. Over the past 5 years, developments have …

Nonalcoholic fatty liver disease (NAFLD) has become the dominant form of chronic liver
disease in children and adolescents with the increasing prevalence of obesity worldwide …

Background & Aims Metabolic-associated fatty liver disease (MAFLD) is common among
adolescents, but the prevalence of significant fibrosis in this age group is not known. We …

Background The frequency of childhood obesity has increased over the last 3 decades, and
the trend constitutes a worrisome epidemic worldwide. With the raising obesity risk, key …

Nonalcoholic fatty liver disease (NAFLD) is characterized by lipotoxicity and ectopic lipid
deposition within hepatocytes. Sulforaphane (SFA), an active compound used for inhibiting …

The prevalence of non-alcoholic fatty liver disease (NAFLD), ranging from simple steatosis
to inflammatory steatohepatitis (NASH) and cirrhosis, continues to rise, making it one of the …

Recently, an expert panel proposed diagnostic criteria for metabolic dysfunction–associated
fatty liver disease (MAFLD) in the pediatric population. The aim of this study was to evaluate …

The incidence of non-alcoholic fatty liver disease (NAFLD) in children is constantly rising.
Lifestyle modification is the cornerstone of the management of pediatric NAFLD. Even …

Machine learning models for predicting non-alcoholic fatty liver disease in the general United
States population: NHANES database - PMC Back to Top Skip to main content NIH NLM Logo …

Non-alcoholic fatty liver disease (NAFLD) is characterized by lipid accumulation within the
liver affecting 1 in 4 people worldwide. As the new silent killer of the twenty-first century …